GoKawiilInsilico's Zhavoronkov Bets Fibrosis Drug Could Also Slow Aging
Alex Zhavoronkov, founder and co-CEO of AI-driven drug discovery company Insilico, is pursuing research suggesting that a treatment developed for fibrosis may have broader anti-aging effects. His work sits within a long personal and scientific interest in longevity research.